CRH Reports Q3 2026 Results, Cuts FY26 Guidance, and Authorizes $6B Share Buyback
CRH PUBLIC LTD CO
Subscribe to track CRH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📢 CRH Public Ltd Co ($CRH) filed an 8-K reporting Q3 2026 financial results.
• Q3 Revenue: $11.4B (+3% YoY) • Q3 Net Income: $1.2B (-22% YoY) • Q3 Adj. EBITDA: $2.7B (flat YoY) • FY26 Guidance Cut: Net Income lowered to $3.1B–$3.3B (prior $3.9B–$4.1B); Adj. EBITDA lowered to $7.8B–$8.0B (prior $8.1B–$8.5B) • Capital Allocation: New $6B share repurchase program authorized through 2030; quarterly dividend raised 5% to $0.39/share • M&A: Completed $8.5B acquisition of Arcosa, Inc. on October 23, 2026.
Comprehensive Analysis
Executive Summary
On October 29, 2026, CRH public limited company (NYSE: CRH) filed a Current Report on Form 8-K under Item 2.02 (Results of Operations and Financial Condition) disclosing its financial results for the third quarter ended September 30, 2026, and revising its full-year 2026 outlook.
Key Financial Highlights
- Q3 2026 Revenue: $11.4 billion, up 3% year-over-year compared to $11.1 billion in Q3 2025, supported by positive pricing momentum and contributions from acquisitions.
- Q3 2026 Net Income: $1.2 billion, declining 22% year-over-year from $1.5 billion, impacted by $178 million in impairment charges in the Philippines reporting unit, higher income tax expense, and transformation costs.
- Q3 2026 Adjusted EBITDA: $2.7 billion, flat compared to Q3 2025; Adjusted EBITDA margin contracted 80 bps to 23.5%.
- Diluted EPS: $1.86 vs. $2.21 in Q3 2025 (-16%); Diluted EPS pre-impairment was $2.09 vs. $2.27 (-8%).
Guidance Revisions
CRH lowered its full-year 2026 outlook citing a challenging cost environment, persistent cost inflation, and subdued residential activity, while incorporating the earlier-than-expected close of Arcosa:
- Net Income: Revised downward to $3.1B – $3.3B (previously $3.9B – $4.1B).
- Adjusted EBITDA: Revised downward to $7.8B – $8.0B (previously $8.1B – $8.5B).
- Diluted EPS: Revised downward to $4.63 – $4.85 (previously $5.60 – $6.05).
- Capital Expenditure: Expected at $2.6B – $2.8B (previously $2.7B – $2.9B).
Major Strategic Announcements
- $6 Billion Share Repurchase Program: The Board authorized a new buyback authorization of up to $6.0 billion expiring at the end of 2030.
- Arcosa Acquisition Completed: On October 23, 2026, CRH finalized the acquisition of Arcosa, Inc. for an enterprise value of approximately $8.5 billion ($150.00/share in cash), funded via term loans, bridge facilities, and cash on hand.
- Operating Model Transformation ('Velocity'): Launched a multi-year program aiming to generate ~$400 million in annual run-rate cost benefits by end of 2028, with estimated non-routine restructuring costs of ~$400 million ($49 million recognized through Q3).
- Dividend Increase: Declared a quarterly dividend of $0.39 per share, up 5% year-over-year, payable December 9, 2026.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
